Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
about
Use of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)Thiopurine S-methyltransferase testing for averting drug toxicity: a meta-analysis of diagnostic test accuracyA common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopeniaThiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: a systematic review.Prospective Evaluation of Pharmacogenomics and Metabolite Measurements upon Azathioprine Therapy in Inflammatory Bowel Disease: An Observational Study.Second Korean guidelines for the management of ulcerative colitis.Inflammatory bowel disease and the elderly: a review.Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis.Management of Inflammatory Bowel Disease in the Elderly.Risk factors for thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype.Pharmacogenetics of inflammatory bowel disease.Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus.NUDT15 polymorphisms are better than thiopurine S-methyltransferase as predictor of risk for thiopurine-induced leukopenia in Chinese patients with Crohn's disease.NUDT15 R139C Variants Increase the Risk of Azathioprine-Induced Leukopenia in Chinese Autoimmune Patients.Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?
P2860
Q26996946-A68E8173-F1E4-4867-B2D3-FA985A2C4F33Q28076780-807A4D5B-1F94-4B20-A6DA-6459BE6ADCA5Q34433052-5B01577C-677F-4FF5-9503-CAAD741C7986Q35971977-D57B9E4B-1296-43DB-B90F-77E6A98B7078Q36822402-F5F2A0E9-FFA4-46B7-B227-33D6B9697CC4Q37662503-7B8D5999-FB34-4564-B3D8-BE1F4F798E3BQ38419578-711AC99B-01E6-4C34-8D16-94E4B29D5651Q38750966-FB4B3589-F4F3-45A6-A046-9D776EBE3D64Q38844393-262556B5-3CB5-487A-B264-977F744ADAC6Q40044141-82CB0D1D-407D-4BE4-AAD1-376CF2147195Q41673937-05BD4B01-F4FD-4FCB-9B20-6BA4AFF98C11Q46927375-91934975-1EBE-4302-817D-1558629A4681Q51529563-C70432D0-B8A6-42A7-8E26-732F85A31B8DQ54975027-4C3E121C-BF69-4961-BB08-14FEB376FEACQ55064299-A20B21E8-7D1D-4660-AEEA-D2E3417E24DC
P2860
Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Should thiopurine methyltransf ...... th inflammatory bowel disease?
@en
Should thiopurine methyltransf ...... th inflammatory bowel disease?
@nl
type
label
Should thiopurine methyltransf ...... th inflammatory bowel disease?
@en
Should thiopurine methyltransf ...... th inflammatory bowel disease?
@nl
prefLabel
Should thiopurine methyltransf ...... th inflammatory bowel disease?
@en
Should thiopurine methyltransf ...... th inflammatory bowel disease?
@nl
P2093
P1476
Should thiopurine methyltransf ...... th inflammatory bowel disease?
@en
P2093
Chen Minhu
Ding Liang
Zhang Fangbin
P304
P356
10.1097/FTD.0B013E3182731925
P577
2012-12-01T00:00:00Z